NCT00222482已完成不适用
A Double-Blind and Placebo Controlled Assessment of Depakote ER in Borderline Personality Disorder
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 15
- 主要终点
- Symptom Checklist 90
研究概览
简要总结
This study examines the effect of Depakote ER versus placebo in a randomized trial of borderline personality disorder. Patients all participate in DBT therapy and those who are not responsive are assigned to either Depakote ER or placebo for up to 12 weeks. Borderline Personality Symtoms are measured and side-effects are assessed.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 21 Years 至 55 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female patients with the diagnosis of borderline personality disorder between the ages of 21 adn 55 years old. Must be in good physical health -
排除标准
- •Major psychiatric illness on Axis I - schizophrenia or bipolar disorder. May not have current MDD. May not be dependent on illicit substances or alcohol.
结局指标
主要结局
Symptom Checklist 90
次要结局
- Barratt Impulsivity Scale
研究者
相似试验
已完成
2 期
Effectiveness of Divalproex Sodium (Depakote) in Treating Children With Temper Outbursts and Severe Mood SwingsMood DisordersNCT00217932National Institute on Drug Abuse (NIDA)15
已完成
3 期
An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and AdolescentsBipolar DisorderNCT00067262Abbott150
已完成
4 期
Abilify in Bipolar Disorder for 24 Weeks Treatment EffectivenessBipolar DisorderNCT00545675Korea Otsuka Pharmaceutical Co., Ltd.146
终止
4 期
Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar IllnessBipolar DisorderNCT00071253Abbott180
已完成
3 期
Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle ChemotherapyNon-Myeloid MalignanciesAnemiaNCT00110955Amgen391